secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001558370-24-015734
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape reports Q3 rev $2.3M (+6.4% YoY); merger with Vyome, asset sale to Biorad for $5.16M
--------------------------------------------------------------------------------

- Q3 revenue $2.3M, up 6.4% YoY and 16.6% sequentially; gross margin 62.8%.
- Operating expenses down 40.6% in first 9 months of 2024 vs 2023.
- Merger with Vyome: ReShape stockholders to own ~11.1% of combined company.
- Asset sale to Biorad for $5.16M cash; includes Lap-Band, Obalon, DBSN systems.
- Received Health Canada approval for Lap-Band 2.0 FLEX and $241K NIH grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837024015734/0001558370-24-015734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837024015734/rsls-20241114x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-015734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer